|
Q3 2019
Filed on Oct 23, 2019
|
544
|
N/A
|
|
|
Q3 2019
Filed on Oct 23, 2019
|
790
|
N/A
|
|
|
Q3 2019
Filed on Oct 23, 2019
|
289
|
$41.69 - $42.7
$12K - $12.3K
|
|
|
Q3 2019
Filed on Oct 23, 2019
|
60
|
$130.07 - $147.8
$7.8K - $8.87K
|
|
|
Q3 2019
Filed on Oct 23, 2019
|
7
|
N/A
|
|
|
Q3 2019
Filed on Oct 23, 2019
|
853
|
$53.15 - $54.55
$45.3K - $46.5K
|
|
|
Q3 2019
Filed on Oct 23, 2019
|
1,237
|
$122.95 - $129.1
$152K - $160K
|
|
|
Q3 2019
Filed on Oct 23, 2019
|
217
|
$160.78 - $175.98
$34.9K - $38.2K
|
|
|
Q3 2019
Filed on Oct 23, 2019
|
12,400
|
$30.69 - $30.76
$381K - $381K
|
|
|
Q3 2019
Filed on Oct 23, 2019
|
279
|
N/A
|
|
|
Q3 2019
Filed on Oct 23, 2019
|
415
|
$123.44 - $131.99
$51.2K - $54.8K
|
|
|
Q3 2019
Filed on Oct 23, 2019
|
3,439
|
$49.51 - $51.84
$170K - $178K
|
|
|
Q3 2019
Filed on Oct 23, 2019
|
1,837
|
$29.39 - $32.57
$54K - $59.8K
|
|
|
Q3 2019
Filed on Oct 23, 2019
|
594
|
$27.61 - $32.46
$16.4K - $19.3K
|
|
|
Q3 2019
Filed on Oct 23, 2019
|
2,195
|
$31.88 - $35.7
$70K - $78.4K
|
|
|
Q3 2019
Filed on Oct 23, 2019
|
900
|
N/A
|
|
|
Q3 2019
Filed on Oct 23, 2019
|
1,105
|
N/A
|
|
|
Q3 2019
Filed on Oct 23, 2019
|
114
|
$125.52 - $127.0
$14.3K - $14.5K
|
|
Contravir Pharmaceuticals In
|
Q3 2019
Filed on Oct 23, 2019
|
1
|
N/A
|
|
|
Q3 2019
Filed on Oct 23, 2019
|
2,416
|
$22.45 - $25.58
$54.2K - $61.8K
|
|
Vanguard Intl Equity Index F
|
Q3 2019
Filed on Oct 23, 2019
|
5,357
|
N/A
|
|
|
Q3 2019
Filed on Oct 23, 2019
|
0
|
N/A
|
|
|
Q2 2019
Filed on Jul 31, 2019
|
3,209
|
$70.09 - $74.72
$225K - $240K
|
|
|
Q2 2019
Filed on Jul 31, 2019
|
10,532
|
$12.7 - $13.36
$134K - $141K
|
|
|
Q2 2019
Filed on Jul 31, 2019
|
2,116
|
N/A
|
|
|
Q2 2019
Filed on Jul 31, 2019
|
9,675
|
$13.1 - $13.84
$127K - $134K
|
|
Rmr Real Estate Income Fd
|
Q2 2019
Filed on Jul 31, 2019
|
5,634
|
N/A
|
|
|
Q2 2019
Filed on Jul 31, 2019
|
22,176
|
$24.07 - $24.57
$534K - $545K
|
|
|
Q2 2019
Filed on Jul 31, 2019
|
2,820
|
$9.32 - $9.91
$26.3K - $27.9K
|
|
|
Q2 2019
Filed on Jul 31, 2019
|
1,716
|
N/A
|
|
|
Q2 2019
Filed on Jul 31, 2019
|
3,849
|
N/A
|
|
|
Q2 2019
Filed on Jul 31, 2019
|
321
|
N/A
|
|
|
Q2 2019
Filed on Jul 31, 2019
|
1,771
|
N/A
|
|
|
Q2 2019
Filed on Jul 31, 2019
|
160
|
N/A
|
|
|
Q2 2019
Filed on Jul 31, 2019
|
4,413
|
N/A
|
|
|
Q2 2019
Filed on Jul 31, 2019
|
360
|
$132.33 - $162.21
$47.6K - $58.4K
|
|
|
Q2 2019
Filed on Jul 31, 2019
|
290
|
N/A
|
|
|
Q2 2019
Filed on Jul 31, 2019
|
2,727
|
$4.56 - $5.14
$12.4K - $14K
|
|
|
Q2 2019
Filed on Jul 31, 2019
|
7,845
|
$22.14 - $23.92
$174K - $188K
|
|
|
Q2 2019
Filed on Jul 31, 2019
|
852
|
$40.43 - $44.3
$34.4K - $37.7K
|
|
Contravir Pharmaceuticals In
|
Q2 2019
Filed on Jul 31, 2019
|
22
|
N/A
|
|
|
Q1 2019
Filed on May 01, 2019
|
1,300
|
N/A
|
|
|
Q1 2019
Filed on May 01, 2019
|
4,205
|
$47.83 - $55.55
$201K - $234K
|
|
|
Q1 2019
Filed on May 01, 2019
|
40
|
$112.86 - $133.3
$4.51K - $5.33K
|
|
|
Q1 2019
Filed on May 01, 2019
|
476
|
N/A
|
|
Invesco Exch Trd Slf Idx Fd
|
Q1 2019
Filed on May 01, 2019
|
1
|
N/A
|
|
|
Q1 2019
Filed on May 01, 2019
|
15
|
N/A
|
|
Blackrock Mun 2018 Term Tr
|
Q1 2019
Filed on May 01, 2019
|
0
|
N/A
|
|
Invesco Exch Trd Slf Idx Fd
|
Q1 2019
Filed on May 01, 2019
|
0
|
N/A
|
|
Invesco Exchange Traded Fd T
|
Q1 2019
Filed on May 01, 2019
|
1,399
|
N/A
|
|